Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rajesh Pahwa, MD
University of Kansas Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California - Irvine
Irvine, California, United States
- Coastal Neurological Medical Group, Inc
La Jolla, California, United States
- University of Southern California
Los Angeles, California, United States
- the Parkinson'S Institute
Sunnyvale, California, United States
- Parkinson'S Disease and Movement Disorder Center of Boca Raton
Boca Raton, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Methodist Plaza Speciality Clinic
Des Moines, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Harvard Vanguard Medical Associates
Boston, Massachusetts, United States
- Henry Ford Health Center - Franklin Pointe
Southfield, Michigan, United States
- Struthers Parkinson'S Center
Golden Valley, Minnesota, United States
- University of Toledo
Toledo, Ohio, United States
- Neurohealth Parkinson Disease and Movement Disorder Center
Warwick, Rhode Island, United States
- Neurology Specialists Dallas
Dallas, Texas, United States
- Etmc Neurological Institute
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2007
- Primary completion
- 30 Sept 2008
- Completion
- 31 Dec 2008
- Last update posted
- 31 Oct 2014
- Registered enrollment
- 77
- Registry id
- NCT00443872
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.